Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial

Journal content Created on 01 Sep 2026 Nature Medicine

Published in

Nature Medicine, Nature Publishing Group

Content

There is no additional content. Please click on the source link to view more information.

Charles E. Geyer Jr.

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement